Page 21 - Binder1
P. 21
Nutrition continued
Medicinal Mushrooms.
Products licence in Japan Extracts from mushrooms:
KRESTIN / PSK (oral) ‐ Digestive, Lung and Breast Cancer
LENTINAN (injection) ‐ Stomach Cancer Lentinan (from shitake mushrooms) ‐ gastrointestinal cancer
SIZOFRAN / SPG (injection) ‐ Cervical Cancer. Grifola frondosa (from mattock mushrooms) ‐ regression of lung, liver,
pancreatic and breast, reductions in side‐effects from chemotherapy
Agaricus subrufescens.
Immune changes induced by mushroom polysaccharide‐based supplementation include:
• Increased NK cell activation Change in Th1‐Th2 immune cell shift, which:
• Increased macrophage activation ‐ Lowered resistance to viral and other pathogens.
• Increased cytotoxic T‐cell activation ‐ Increases in fatigue and incidence of depression.
• Increased IFN‐γ, IL‐2 and TNF‐β production ‐ Increases incidence of allergic and auto‐immune conditions such as asthma
• Reduced IL‐4 production and SLE.
• Inhibition of prostaglandin synthesis ‐ Persistent humoral immune responses exacerbate recruitment and
activation of innate immune cells in neoplastic microenvironments where
they regulate tissue remodeling, pro‐angiogenic and pro‐survival pathways
that together potentiate cancer development.1.